# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-037242
Filing Date
2024-03-27
Accepted
2024-03-27 16:31:09
Documents
124
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | gyre-20231231.htm iXBRL | 10-K | 4377013
2 | EX-3.6(B) | gyre-ex3_6b.htm | EX-3.6(B) | 12439
3 | EX-4.1 | gyre-ex4_1.htm | EX-4.1 | 44294
4 | EX-21.1 | gyre-ex21_1.htm | EX-21.1 | 9244
5 | EX-23.1 | gyre-ex23_1.htm | EX-23.1 | 4082
6 | EX-31.1 | gyre-ex31_1.htm | EX-31.1 | 14769
7 | EX-31.2 | gyre-ex31_2.htm | EX-31.2 | 14558
8 | EX-32.1 | gyre-ex32_1.htm | EX-32.1 | 7904
9 | EX-32.2 | gyre-ex32_2.htm | EX-32.2 | 7734
10 | EX-97.1 | gyre-ex97_1.htm | EX-97.1 | 32423
11 | GRAPHIC | img98921446_0.jpg | GRAPHIC | 108531
12 | GRAPHIC | img98921446_1.jpg | GRAPHIC | 165653
13 | GRAPHIC | img98921446_2.jpg | GRAPHIC | 2311
14 | GRAPHIC | img98921446_3.jpg | GRAPHIC | 155614
15 | GRAPHIC | img98921446_4.jpg | GRAPHIC | 24230
16 | GRAPHIC | img98921446_5.jpg | GRAPHIC | 113011
| Complete submission text file | 0000950170-24-037242.txt |  | 18521271

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
17 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | gyre-20231231.xsd | EX-101.SCH | 2449568
128 | EXTRACTED XBRL INSTANCE DOCUMENT | gyre-20231231_htm.xml | XML | 2911487

Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51173 | Film No.: 24791282
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)